ViQi and Araceli Biosciences Collaborate on AI-Driven Phenotypic Profiling

ViQi, Inc. and Araceli Biosciences have announced a collaboration to integrate ViQi's AI-powered image analysis technology with Araceli's high-throughput imaging platform. This partnership aims to enhance AI-driven phenotypic profiling in high-throughput cell-based assays, announced in a press release.

The collaboration will leverage ViQi's advanced image analysis capabilities with Araceli's Endeavor Ultra High Throughput – High Content Imaging Platform. This integration is expected to improve the analysis of large imaging datasets, enabling scientific labs to generate and analyze data more efficiently. ViQi's CEO, Kathy Yeung, highlighted the value of AI-driven analysis in extracting meaningful insights from vast amounts of imaging data.

Araceli's CEO, Matt Beaudet, emphasized the importance of making biological datasets usable in real-time, noting that the collaboration with ViQi will bring structure, speed, and insight to complex phenotypic data. The partnership is set to transform how imaging assays are developed and utilized in scientific research.